Drug discovery is a long, expensive process that’s hard to complete outside of the large pharmaceutical corporate paradigm. Thirty years ago, our own Professor Duncan Hunter came up with a simple but brilliant idea for treating a rare cancer and pushed it towards development, and finally patients with adrenal cancer have a new potential treatment. Drugs without a large monetary value, often called orphan drugs, are seldomly developed by profit-oriented businesses, and we applaud Prof. Hunter’s effort and ultimate success. Here is more information about this intriguing story that also highlights the importance of basic scientific research:
A CBC interview with Prof. Hunter:
The Western News story:
The FDA announcement:
Congratulations, Duncan! We all applaud your efforts and this important achievement.
Update September 21, 2018, a Story in Canadian Chemical News: